{"DataElement":{"publicId":"2677480","version":"1","preferredName":"Trastuzumab Agent Second Dose Not Administered Reason","preferredDefinition":"the reason the second dose or amount of trastuzumab, a humanized recombinant monoclonal antibody directed against the HER2- receptor protein, was not administered.","longName":"TR_AG_S_DO_N_AD_RSN","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2677422","version":"1","preferredName":"Trastuzumab Agent Second Dose Not Administered","preferredDefinition":"information related to the second dose or amount of trastuzumab, a humanized recombinant monoclonal antibody directed against the HER2- receptor protein, not being administered.","longName":"TRAS_AGT_S_DOS_N_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2322168","version":"1","preferredName":"Trastuzumab Agent","preferredDefinition":"A humanized recombinant monoclonal antibody directed against the HER2- receptor protein.  Trastuzumab binds to the extracellular domain of the growth factor protein HER2, thereby inhibiting proliferation of HER2 overexpressing tumor cells.  Binding with HER2 protein also initiates an antibody-dependent cell cytotoxicity.(NCI):An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1647:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trastuzumab","conceptCode":"C1647","definition":"A recombinant humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). After binding to HER2 on the tumor cell surface, trastuzumab induces an antibody-dependent cell-mediated cytotoxicity against tumor cells that overexpress HER2. HER2 is overexpressed by many adenocarcinomas, particularly breast adenocarcinomas. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD0F852B-049E-7140-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-08-02","modifiedBy":"ONEDATA","dateModified":"2005-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2677420","version":"1","preferredName":"Second Dose Not Administered","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude.:The amount of medicine taken, or radiation given, at one time.:An operation in which a term denies or inverts the meaning of another term or construction.:Given.","longName":"C25666:C25488:C25594:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3967A469-C1DE-354A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3967A469-C1EF-354A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2677479","version":"1","preferredName":"Agent Not Administered Reason","preferredDefinition":"the reason an agent was not administered.","longName":"AGT_N_ADM_RSN","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396938BF-D665-6F82-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"CAMPBELB","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 2, 3, or 4 allergic reaction/hypersensitivity (including drug fever)","valueDescription":"Grade 2, 3, or 4 allergic reaction/hypersensitivity (including drug fever)","ValueMeaning":{"publicId":"2677481","version":"1","preferredName":"Grade 2, 3, or 4 allergic reaction/hypersensitivity (including drug fever)","longName":"2677481","preferredDefinition":"Grade 2, 3, or 4 allergic reaction/hypersensitivity (including drug fever)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3969216B-89B0-3B68-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F982-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 3 or 4 cardiac ischemia/infarction","valueDescription":"Grade 3 or 4 cardiac ischemia/infarction","ValueMeaning":{"publicId":"2677482","version":"1","preferredName":"Grade 3 or 4 cardiac ischemia/infarction","longName":"2677482","preferredDefinition":"Grade 3 or 4 cardiac ischemia/infarction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39694446-AAF2-58A0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F994-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 2, 3, or 4 cytokine release syndrome/acute infusion reaction","valueDescription":"Grade 2, 3, or 4 cytokine release syndrome/acute infusion reaction","ValueMeaning":{"publicId":"2677483","version":"1","preferredName":"Grade 2, 3, or 4 cytokine release syndrome/acute infusion reaction","longName":"2677483","preferredDefinition":"Grade 2, 3, or 4 cytokine release syndrome/acute infusion reaction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39694600-038B-0513-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F9A6-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 3 or 4 left ventricular systolic dysfunction","valueDescription":"Grade 3 or 4 left ventricular systolic dysfunction","ValueMeaning":{"publicId":"2677484","version":"1","preferredName":"Grade 3 or 4 left ventricular systolic dysfunction","longName":"2677484","preferredDefinition":"Grade 3 or 4 left ventricular systolic dysfunction","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39690BB2-E66C-162D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F9B8-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Grade 3 or 4 other clinically significant AEs","valueDescription":"Grade 3 or 4 other clinically significant AEs","ValueMeaning":{"publicId":"2677485","version":"1","preferredName":"Grade 3 or 4 other clinically significant AEs","longName":"2677485","preferredDefinition":"Grade 3 or 4 other clinically significant AEs","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3967BB88-7501-3A7C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"396948E7-F9CA-0861-E044-0003BA3F9857","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ONEDATA","dateModified":"2007-09-05","deletedIndicator":"No"},{"value":"Pulmonary Toxicity","valueDescription":"Pulmonary Toxicity","ValueMeaning":{"publicId":"2871574","version":"1","preferredName":"Pulmonary Toxicity","longName":"2871574","preferredDefinition":"Relating to the lungs.: Toxicity; the degree to which something is poisonous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69442CAD-A1E6-A995-E040-BB89AD4320DF","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-05-06","modifiedBy":"ONEDATA","dateModified":"2009-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C8379-A625-BB84-E040-BB89AD437E25","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"ONEDATA","dateModified":"2009-09-25","deletedIndicator":"No"},{"value":"Other non-heme toxicity","valueDescription":"Other non-heme toxicity","ValueMeaning":{"publicId":"2947245","version":"1","preferredName":"Other non-heme toxicity","longName":"2947245","preferredDefinition":"Other non-heme toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74B9639F-F184-0172-E040-BB89AD436135","latestVersionIndicator":"Yes","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"74B9639F-F19D-0172-E040-BB89AD436135","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"ONEDATA","dateModified":"2009-09-29","deletedIndicator":"No"},{"value":"Heme toxicity","valueDescription":"Heme toxicity","ValueMeaning":{"publicId":"2947238","version":"1","preferredName":"Heme toxicity","longName":"2947238","preferredDefinition":"Heme toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74B9E8DE-DBA0-BE28-E040-BB89AD4363B5","latestVersionIndicator":"Yes","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"74B9E8DE-DBB9-BE28-E040-BB89AD4363B5","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"ONEDATA","dateModified":"2009-09-29","deletedIndicator":"No"},{"value":"Cardiac toxicity","valueDescription":"Cardiac Toxicity","ValueMeaning":{"publicId":"2684343","version":"1","preferredName":"Cardiac Toxicity","longName":"2684343","preferredDefinition":"Cardiac Toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AE5174E-8DAE-37C3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"74B9E8DE-DBCD-BE28-E040-BB89AD4363B5","beginDate":"2009-09-29","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-29","modifiedBy":"ONEDATA","dateModified":"2009-09-29","deletedIndicator":"No"},{"value":"No missed doses","valueDescription":"No missed doses","ValueMeaning":{"publicId":"2946192","version":"1","preferredName":"No missed doses","longName":"2946192","preferredDefinition":"No missed doses","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746C7E63-C742-9922-E040-BB89AD437B52","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C7F31-9B80-D59D-E040-BB89AD437B66","beginDate":"2009-09-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-09-25","modifiedBy":"ONEDATA","dateModified":"2009-09-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"396938B8-0BD3-5EBC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"ALAIS","dateModified":"2009-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"},{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"},{"publicId":"2811909","version":"1","longName":"Leukemia","context":"CTEP"},{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Reason trastuzumab was discon","type":"Preferred Question Text","description":"Reason trastuzumab was discontinued after Dose 1","url":null,"context":"CTEP"}],"origin":"NSABP CRF:National Surgical Adjuvant Breast and Bowel Project Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"39691F6B-A414-4FA3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-09-05","modifiedBy":"CAMPBELB","dateModified":"2008-07-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}